Episiotomy, Post-partum Perineal Pain, Vaginal Tear
Conditions
Keywords
Post-partum Perineal pain, Episiotomy, First-degree tear
Brief summary
The aim of this placebo-controlled clinical trial is to assess the effectiveness of the local infiltration of the analgesic Chirocaïne® on perineal pain after episiotomy or first-degree tear. The pain intensity is measured in immediate postpartum period by using a numerical rating scale (NRS) at the following times: H2, H4, H8, H12, H24, H36, H48 during rest, defecation and during activities. The safety of Chirocaïne® and the patient satisfaction are also evaluated at each time.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Inclusion Criteria: * Patients aged 18-45 years * Single pregnancy. * Vaginal normal birth in cephalic presentation or assisted vaginal delivery by vacuum extractor. * Patients having a mediolateral episiotomy or a first-degree perineal tear, epidural analgesia. * Patients affiliated to a national insurance scheme * Patients who have given their written consent
Exclusion criteria
* Patient not speaking, reading, writing French. * Multiple pregnancy. * Breech delivery or instrumental delivery by forceps or spatula. * Intact perineum. * No epidural analgesia. * Patient who represent contraindication to local anesthetics, severe arterial hypotension. * Previous tear requiring sutures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-partum perineal pain measured by a numerical rating scale | 8 hours post partum |
Countries
France